保龄宝生物股份有限公司 公司作为国内重要的功能糖制造商，玉米、玉米淀粉、蔗糖等原材料在产品 成本中占较大比重。为充分利用期货、期权市场功能，有效控制原料价格风险， 锁定经营成本和利润，增强抗风险能力，合理规避原料价格波动给经营带来的不 利影响，提升企业经营水平，保障企业健康运行，拟继续开展套期保值业务。 二、公司拟开展的套期保值业务概述 1.交易品种 公司进行套期保值业务的期货、期权品种，只限于生产经营相关的产品或者 所需的原材料，包括玉米、玉米淀粉、白糖的场内期货品种及场外期权品种。 关于开展套期保值业务的可行性分析报告 保龄宝生物股份有限公司（以下简称"公司"）拟使用自有资金开展与生产经 营相关产品的套期保值业务。 一、套期保值业务开展的目的及必要性 公司拟交易的场外期权产品属于非标准化合约，主要为平抑公司原材料及产 成品所面临的价格波动风险，公司开展场外期权业务的交易对手方将选择具备相 应资质的交易商。 2.交易金额 未来十二个月内，预计动用的交易保证金和权利金上限在任一时点金额不超 过 5,000 万元（其中期权部分不超过 100 万元），预计任一交易日持有的最高合 约价值不超过 40,000 万元； ...

Core Viewpoint - Baolingbao (002286.SZ) reported a strong performance in the third quarter, with significant year-on-year growth in both revenue and net profit [1] Financial Performance - The company's operating revenue for the first three quarters reached 2.126 billion yuan, representing a year-on-year increase of 15.98% [1] - The net profit attributable to shareholders of the listed company was 134 million yuan, showing a year-on-year growth of 32.58% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 125 million yuan, reflecting a year-on-year increase of 31.12% [1]

公司董事会及全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、会议召开情况 保龄宝生物股份有限公司（以下简称"保龄宝"或"公司"）关于召开第六 届董事会第十四次会议的通知于 2025 年 10 月 22 日以电子邮件的方式发出，会 议于 2025 年 10 月 28 日以通讯表决的方式召开。会议应参加表决的董事 9 人， 实际表决的董事 9 人。会议的召开符合《公司法》和《公司章程》等法规的规定。 证券代码：002286 证券简称：保龄宝 公告编号：2025-057 保龄宝生物股份有限公司 第六届董事会第十四次会议决议公告 1 3.会议以 9 票同意，0 票反对，0 票弃权，审议通过《关于开展套期保值业 务的可行性分析报告》 根据《深圳证券交易所上市公司自律监管指引第 7 号—交易与关联交易》及 其他有关法律、法规、规范性文件以及《公司章程》的有关规定，结合公司的实 际情况，公司制定了《关于开展套期保值业务的可行性分析报告》。 详情见与本决议公告同日发布在巨潮资讯网(http://www.cninfo.com.cn) 上的《关于开展套期保值业务的可行性分析报告》。 三、备 ...

Core Insights - The company reported a third-quarter revenue of 727 million yuan, representing a year-on-year growth of 12.23% [1] - The net profit for the third quarter was 41.33 million yuan, showing a year-on-year increase of 30.21% [1] - For the first three quarters of 2025, the company achieved a revenue of 2.126 billion yuan, which is a year-on-year growth of 15.98% [1] - The net profit for the first three quarters reached 134 million yuan, reflecting a year-on-year increase of 32.58% [1] - The basic earnings per share stood at 0.36 yuan [1] Revenue and Profit Analysis - The growth in revenue and profit is primarily attributed to significant year-on-year increases in sales of core products such as sugar-reduced sweeteners, prebiotics, and dietary fibers [1] - The revenue contribution from core products has been continuously increasing [1] - Cost reduction and efficiency improvements have led to an enhancement in gross profit margin [1]

保龄宝生物股份有限公司 2025 年第三季度报告 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 证券代码：002286 证券简称：保龄宝 公告编号：2025-058 保龄宝生物股份有限公司 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 保龄宝生物股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 727,126,837.74 | 12.23% | 2,126,36 ...

证券日报网讯保龄宝（002286）10月23日在互动平台回答投资者提问时表示，截至2025年10月20日，公 司股东总户数为33680户。 ...

Group 1 - Sanfu Co., Ltd. (603938.SH) reported that the revenue from storage chips accounts for less than 1% of its total operating income [1] - Ningde Times (300750.SZ) achieved a net profit of 18.549 billion yuan in the third quarter, representing a year-on-year growth of 41.21% [1] - China Shipbuilding (600150.SH) expects a year-on-year increase of 104.30% in net profit for the first three quarters, reaching 12.639 billion yuan [2] - iFlytek (002230.SZ) reported a year-on-year growth of 202.4% in net profit for the third quarter [2] Group 2 - Yucai Resources (002998.SZ) plans to invest 150 million yuan in the construction of a composite new materials production base project [1] - Dashi Intelligent (002421.SZ) won a smart transportation project contract worth 96 million yuan [1] - GQY Vision (300076.SZ) is acquiring 70% of Taihen Optoelectronics [1] - Dongtu Technology (300353.SZ) intends to purchase 100% of Gaoweike's equity and raise matching funds, leading to a stock suspension [1] - Changhong Huayi (000404.SZ) has repurchased 1.03% of its shares [1] - Junsheng Electronics (600699.SH) has a subsidiary that recently secured a project for automotive intelligent electrification [2] - Jinxinno (300252.SZ) plans to raise no more than 292 million yuan through a private placement for the expansion of data center high-speed interconnection products [2]

Group 1 - The major shareholder of Baolingbao, Ningbo Baopu Futong Asset Management Center, plans to reduce its stake by up to 11.417 million shares, representing no more than 3% of the company's total share capital, within a three-month period from November 11, 2025, to February 10, 2026 [1] - The reduction will occur through centralized bidding and block trading, with a limit of 2% (7.6113 million shares) via block trading and 1% (3.8057 million shares) via centralized bidding within any consecutive 90-day period [1] - Baolingbao stated that this share reduction is a normal behavior of the shareholder and will not significantly impact the company's governance structure, equity structure, or future operations, nor will it lead to a change in control [1] Group 2 - Baolingbao primarily engages in the research, production, and sales of functional ingredients such as prebiotics, dietary fibers, and sugar-reducing sweeteners [2] - In 2024, the company achieved operating revenue of 2.402 billion yuan, a year-on-year decrease of 4.84%, while the net profit attributable to shareholders increased by 105.97% to 111 million yuan [2] - For the first half of this year, Baolingbao reported operating revenue of 1.399 billion yuan, a year-on-year increase of 18.02%, and a net profit attributable to shareholders of 92.672 million yuan, up 33.66% [2]

格隆汇10月21日｜保龄宝(002286.SZ)盘中跌5.22%至9.26元，股价创今年5月19日以来逾5个月新低。保 龄宝公告，持股7.10684%的股东宁波趵朴富通资产管理中心(有限合伙)计划自公告披露之日起15个交易 日后的2025年11月11日至2026年2月10日，通过集中竞价和大宗交易方式合计减持不超过1141.7万股， 占公司总股本3%。(格隆汇) ...

Group 1 - The stock of Baolingbao fell by 5.02% on October 21, closing at 9.28 CNY per share, with a trading volume of 77.45 million CNY and a turnover rate of 2.23%, resulting in a total market capitalization of 3.532 billion CNY [1] - Baolingbao Biotech Co., Ltd. is located in Dezhou, Shandong Province, and was established on October 16, 1997, with its listing date on August 28, 2009. The company's main business involves the research, production, and sales of functional sugars [1] - The revenue composition of Baolingbao includes: starch sugars and others 29.89%, sugar-reduced sweeteners 26.55%, feed and by-products 22.40%, probiotics 13.48%, dietary fiber 7.39%, and others (supplements) 0.29% [1] Group 2 - From the perspective of the top ten holdings of funds, one fund under Western Li De has a significant position in Baolingbao. The Western Li De New Fortune Mixed A Fund (673120) held 14,400 shares in the second quarter, accounting for 4.17% of the fund's net value, ranking as the seventh largest holding [2] - The Western Li De New Fortune Mixed A Fund (673120) was established on June 16, 2017, with a latest scale of 1.8184 million. Year-to-date, it has lost 5.36%, ranking 8106 out of 8162 in its category; over the past year, it has lost 7.13%, ranking 7959 out of 8024; since inception, it has achieved a return of 27.84% [2] Group 3 - The fund manager of Western Li De New Fortune Mixed A (673120) is Zhang Changping, who has been in the position for 4 years and 352 days. The total asset scale of the fund is 1.568 billion CNY, with the best fund return during his tenure being 111.93% and the worst being 0.88% [3]